The provided materials detail a multiple-award Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) to Organogenesis Inc., a leading regenerative medicine company. The contract, worth up to $2.1 billion over five years, is for the procurement of various biologics and biological implants, including allografts from human cadavers and xenografts from animals, to be used in VA medical procedures and surgeries.
Organogenesis Inc. has been awarded several delivery orders under this IDC, valued at approximately $27,000 and $9,000, for the provision of surgical implants and wound matrices. These orders were placed by the VA's Veterans Integrated Service Networks, indicating the company's role as a key supplier of regenerative medicine products to support the healthcare needs of veterans. Organogenesis also holds other significant IDVs with the VA and the Defense Logistics Agency, further positioning the company as a major provider of biologics and surgical implants to the federal government.
Generated 8/30/24, 6:21 PM